↓ Skip to main content

Beta blockers for peripheral arterial disease

Overview of attention for article published in Cochrane database of systematic reviews, September 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Beta blockers for peripheral arterial disease
Published in
Cochrane database of systematic reviews, September 2013
DOI 10.1002/14651858.cd005508.pub3
Pubmed ID
Authors

Sharath Chandra Vikram Paravastu, Derick A Mendonca, Anthony Da Silva

Abstract

Beta (β) blockers are indicated for use in coronary artery disease (CAD). However, optimal therapy for people with CAD accompanied by intermittent claudication has been controversial because of the presumed peripheral haemodynamic consequences of beta blockers, leading to worsening symptoms of intermittent claudication. This is an update of a review first published in 2008.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 1 8%
Professor 1 8%
Unknown 11 85%
Readers by discipline Count As %
Nursing and Health Professions 1 8%
Medicine and Dentistry 1 8%
Unknown 11 85%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2018.
All research outputs
#8,245,387
of 13,652,000 outputs
Outputs from Cochrane database of systematic reviews
#8,807
of 10,697 outputs
Outputs of similar age
#65,156
of 131,400 outputs
Outputs of similar age from Cochrane database of systematic reviews
#88
of 118 outputs
Altmetric has tracked 13,652,000 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 10,697 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 131,400 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 118 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.